New trial examines the effectiveness of combination immunotherapy for platinum-resistant ovarian cancer

A new clinical trial studying the effectiveness of a combination of immunotherapy treatments could be more effective for patients with ovarian cancer who are resistant to traditional interventions.

Related Keywords

New York ,United States ,Florida ,Chicago ,Illinois ,American ,Thomas Herzog ,Emily Henderson ,University Of Cincinnati Cancer Center ,Alkermes ,American Society Of Clinical Oncology ,University Of Cincinnati Thomas Herzog ,Drug Administration ,Uc Health ,Uc College Of Medicine ,American Society ,Clinical Oncology ,Annual Meeting ,Cincinnati Cancer Center ,Carolyn Flory Professor ,Gynecologic Oncology ,Cancer ,Immunotherapy ,Ovarian Cancer ,Chemotherapy ,Clinical Trial ,Drugs ,Immune System ,Ncology ,Surgery ,